LFG
NUVB icon

Larson Financial Group’s Nuvation Bio NUVB Stock Holding History

Larson Financial Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,400
Closed -$20K – 3605
2025
Q3 		$20K Hold
5,400
– – ﹤0.01% 1649
2025
Q2 		$10.5K Buy
5,400
+1,400
+35% +$2.92K ﹤0.01% 1787
2025
Q1 		$7.04K Hold
4,000
– – ﹤0.01% 1767
2024
Q4 		$10.6K Hold
4,000
– – ﹤0.01% 1460
2024
Q3 		$9.16K Buy
+4,000
New +$12.2K ﹤0.01% 1507

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Larson Financial Group's NUVB Position: Q4 2025 in Review

Larson Financial Group sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 5,400 shares — an estimated $20K sold.

Larson Financial Group first reported a position in NUVB in Q3 2024 and held it in 5 quarters. The position peaked at $20K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Larson Financial Group reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Larson Financial Group sold 5,400 Nuvation Bio shares in Q4 2025, an estimated $20K.
  • Larson Financial Group first reported a position in Nuvation Bio in Q3 2024 and held it in 5 quarters.
  • Larson Financial Group's Nuvation Bio position peaked at $20K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.